Valdecoxib, a selective inhibitor of the cyclooxygenase-2 enzyme and classified as a non-steroidal anti-inflammatory drug (NSAID), was previously used in the treatment of arthritis, rheumatoid arthritis, and pain associated with menstrual periods [84]. This evidence concerns the gene PTGS2 and arthritic joint disease.